Stanford-SLAC CryoEM Center (S2C2) User Access

NIH Bridge2AI Stage 2 represents the next phase of the NIH Common Fund Bridge to Artificial Intelligence program building on $130 million invested in Stage 1 to create ethically sourced AI-ready biomedical datasets. Stage 2 shifts focus from data generation to building tools devices and safety frameworks that translate those datasets into clinical and research applications. Two interconnected initiatives are funded: Innovation Funnels supporting teams that use Stage 1 AI-ready datasets to create practical tools including diagnostic algorithms drug discovery platforms and clinical decision support systems that demonstrate measurable health impact and a Network for AI Health Science developing safety measures validation protocols and responsible-use frameworks for AI in health research. The program values interdisciplinary teams combining computational scientists with domain experts in specific disease areas. Stage 2 Requests for Applications are expected by mid-2026. This is distinct from ARPA-H programs which fund specific high-risk clinical AI applications and from AHRQ healthcare AI safety grants which examine existing AI impact on healthcare systems.

National Center for CryoEM Access and Training (NCCAT) User Access is sponsored by National Institutes of Health Common Fund. NCCAT provides researchers access to state-of-the-art equipment, technical support, and instruction for the production and analysis of high-resolution data using cryo-EM technology. It also works to develop an expert workforce of cryo-EM practitioners.

Pacific Northwest Cryo-EM Center (PNCC) User Access is sponsored by National Institutes of Health Common Fund. The Pacific Northwest Center for Cryo-EM (PNCC) is a national user facility offering free access to state-of-the-art workflows for single particle analysis and electron tomography for new and experienced cryo-EM researchers. It also provides individual and group training related to sample analysis and optimization, grid preparation and screening, (semi-)automated data collection, image analysis, and 3D reconstruction.

NCI Continuing Umbrella of Research Experiences (CURE) Academic Career Excellence (ACE) Award (K32) is a grant from the National Cancer Institute (NCI) that funds early postdoctoral fellows from diverse backgrounds, including underrepresented groups, to pursue research training in cancer-related fields. The K32 award supports fellows within 12 months prior to transitioning into, or within the first two years of, a postdoctoral position. The program, operated through NCI's Center to Reduce Cancer Health Disparities (CRCHD), aims to enhance the pool of qualified diverse cancer researchers. Beginning with the June 12, 2025 due date, the CURE ACE Award is available in both Independent Clinical Trial Required and Independent Clinical Trial Not Allowed versions. Eligible applicants must be U.S. citizens or permanent residents at time of award.

Innovation Grant is a grant from the Delta Dental of Arizona Foundation that funds nonprofit organizations pursuing unique, high-impact projects that improve health and wellness in Arizona communities. This two-year award supports original initiatives with measurable real-world impact, including programs serving underserved and uninsured populations through oral health education, disease prevention, and nutritional access. Projects must demonstrate the potential to make a meaningful difference in the community and stand apart from conventional approaches. Eligible applicants are Arizona-based nonprofit organizations. Awards total $100,000 per recipient over two years. The 2026 application cycle closed October 16, 2025, with recipients notified in late 2025 and funding made available shortly after.